FRANKLIN RESOURCES INC – Regeneron Pharmaceuticals, Inc. Transaction History
FRANKLIN RESOURCES INC portfolio value:
$362.48M
portfolio value
FRANKLIN RESOURCES INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.29% | 1.51K shares | 52.32M | $688.87 | 526.19K |
| Q2 2022 | share | Decrease | -6.93% | -39.07K shares | -83.58M | $591.13 | 524.68K |
| Q1 2022 | share | Decrease | -10.86% | -68.68K shares | -5.67M | $698.42 | 563.76K |
| Q4 2021 | share | Increase | +4.43% | 26.80K shares | 32.89M | $642.51 | 632.44K |
| Q3 2021 | share | Decrease | -1.16% | -7.13K shares | 24.26M | $605.18 | 605.64K |
| Q2 2021 | share | Increase | +3.86% | 22.78K shares | 63.11M | $558.54 | 612.78K |
| Q1 2021 | share | Decrease | -4.25% | -26.18K shares | -18.53M | $473.14 | 590.00K |
| Q4 2020 | share | Decrease | -14.48% | -104.34K shares | -105.68M | $483.11 | 616.18K |
| Q3 2020 | share | Increase | +3.86% | 26.79K shares | -38.89M | $559.78 | 720.53K |
| Q2 2020 | share | Increase | +19.02% | 110.87K shares | 157.66M | $623.65 | 693.74K |
| Q1 2020 | share | Decrease | -11.58% | -76.31K shares | 37.09M | $488.29 | 582.86K |
| Q4 2019 | share | Decrease | -6.10% | -42.83K shares | 52.77M | $375.48 | 659.18K |
| Q3 2019 | share | Increase | +2.96% | 20.20K shares | -18.66M | $277.4 | 702.01K |
| Q2 2019 | share | Increase | +19.69% | 112.14K shares | -20.50M | $313 | 681.80K |
| Q1 2019 | share | Decrease | -1.73% | -10.04K shares | 17.39M | $410.62 | 569.66K |
| Q4 2018 | share | Decrease | -11.21% | -73.17K shares | -47.27M | $373.5 | 579.70K |
| Q3 2018 | share | Decrease | -5.37% | -37.07K shares | 25.76M | $404.04 | 652.88K |
| Q2 2018 | share | Decrease | -10.15% | -77.90K shares | -26.41M | $344.99 | 689.95K |
| Q1 2018 | share | Decrease | -6.34% | -51.93K shares | -43.76M | $344.36 | 767.86K |
| Q4 2017 | share | Increase | +4.48% | 35.12K shares | -42.63M | $375.96 | 819.79K |
| Q3 2017 | share | Increase | +1.08% | 8.41K shares | -30.40M | $447.12 | 784.67K |
| Q2 2017 | share | Decrease | -4.51% | -36.69K shares | 66.22M | $491.14 | 776.25K |
| Q1 2017 | share | Decrease | -10.82% | -98.67K shares | -19.63M | $387.51 | 812.95K |
| Q4 2016 | share | Increase | +16.32% | 127.89K shares | 19.57M | $367.09 | 911.62K |
| Q3 2016 | share | Increase | +2.74% | 20.90K shares | 48.67M | $402.02 | 783.73K |
| Q2 2016 | share | Increase | +14.32% | 95.55K shares | 25.89M | $349.23 | 762.83K |
| Q1 2016 | share | Increase | +4.80% | 30.56K shares | -105.14M | $360.44 | 667.28K |